Skip to main content
Veterinary Medicines

Felinta 15 mg prolonged-release tablets for cats

Authorised
  • Carbimazole

Product identification

Medicine name:
Felinta 15 mg prolonged-release tablets for cats
FELINTA 15 MG COMPRIMES A LIBERATION PROLONGEE POUR CHATS
Active substance:
  • Carbimazole
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carbimazole
    15.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Prolonged-release tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03BB01
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • (ID2) 100 Prolonged-release tablet: Box (Cardboard) with 10 Blister (PolyVinyl Chloride; Aluminium; Orientated PolyAmide) each with 10 Prolonged-release tablet, closed with Foil (Aluminium)
  • (ID1) 30 Prolonged-release tablet: Box (Cardboard) with 3 Blister (PolyVinyl Chloride; Aluminium; Orientated PolyAmide) each with 10 Prolonged-release tablet, closed with Foil (Aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Billev Pharma East registration of medicines Ltd.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Tiofarma B.V.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7352311 6/2022
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0341/002
Concerned member states:
  • France

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 9/04/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025